9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

Estimated reading time: < 1 min

Condition: Malignant Mesothelioma

Estimated Enrollment: 47

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: Survival,  Failure free survival,  ,

Interventions: PTK787/ZK 222584,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: July 2005

Completion Date: June 2006

Last  Posted Date: July 1, 2016

Location: Northeast Alabama Regional Medical Center, Anniston, Alabama, United States

Website Link: https://ClinicalTrials.gov/show/NCT00053885

Was this article helpful?
Dislike 0